Ontology highlight
ABSTRACT: Background
Angiotensin receptor-neprilysin inhibitor (ARNI) prescription in the United States remains suboptimal despite strong evidence for efficacy and value in heart failure with reduced ejection fraction. Factors responsible for under prescription are not completely understood. Economic limitations may play a disproportionate role in reduced access for some patients.Methods
This is an analysis of the Get With The Guidelines-Heart Failure registry, supplemented with data from the Distressed Community Index. Data were fit to a mixed-effects regression model to investigate clinical and socioeconomic factors associated with ARNI prescription at hospital discharge. Missing data were handled by multilevel multiple imputation.Results
Of the 136 144 patients included in
SUBMITTER: Tran JS
PROVIDER: S-EPMC9673159 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature